TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
Background: Experimental studies suggest that angiotensin II plays a central role in the pathogenesis of abdominal aortic aneurysm. This trial aims to evaluate the efficacy of the angiotensin receptor blocker telmisartan in limiting the progression of abdominal aortic aneurysm. Methods/Design: Telmi...
| Main Authors: | Morris, D., Cunningham, M., Ahimastos, A., Kingwell, B., Pappas, E., Bourke, M., Reid, Christopher, Stijnen, T., Dalman, R., Aalami, O., Lindeman, J., Norman, P., Walker, P., Fitridge, R., Bourke, B., Dear, A., Pinchbeck, J., Jaeggi, R., Golledge, J. |
|---|---|
| Format: | Journal Article |
| Published: |
BioMed Central Ltd.
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/38418 |
Similar Items
Erratum to: 'TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial'
by: Morris, D.R., et al.
Published: (2016)
by: Morris, D.R., et al.
Published: (2016)
Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): Study protocol for a randomised controlled trial
by: Rowbotham, S., et al.
Published: (2017)
by: Rowbotham, S., et al.
Published: (2017)
Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: Outcomes from the FAME-2 trial
by: Pinchbeck, J., et al.
Published: (2018)
by: Pinchbeck, J., et al.
Published: (2018)
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): Study protocol for a randomised controlled trial
by: Rowbotham, S., et al.
Published: (2017)
by: Rowbotham, S., et al.
Published: (2017)
Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: A randomized controlled trial
by: Ahimastos, A., et al.
Published: (2013)
by: Ahimastos, A., et al.
Published: (2013)
Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])
by: Cowan, B., et al.
Published: (2009)
by: Cowan, B., et al.
Published: (2009)
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristics
by: Cowan, B., et al.
Published: (2009)
by: Cowan, B., et al.
Published: (2009)
Investigation of the reasons for copper and gold loss in the cleaner tail, at Ok Tedi, Papua New Guinea
by: Erepan, Peter
Published: (2004)
by: Erepan, Peter
Published: (2004)
Telmisartan to prevent recurrent stroke and cardiovascular events
by: Yusuf, Salim, et al.
Published: (2008)
by: Yusuf, Salim, et al.
Published: (2008)
Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
by: Sengupta, Pinaki Ranjan, et al.
Published: (2017)
by: Sengupta, Pinaki Ranjan, et al.
Published: (2017)
Improved solubility of telmisartan by using freeze-dried solid dispersion method
by: Aljapairai, Khater Ahmed Saeed, et al.
Published: (2017)
by: Aljapairai, Khater Ahmed Saeed, et al.
Published: (2017)
Beneficial alteration of blood biochemical parameters by Telmisartan-Pioglitazone combination in rat
by: Ibrahim, Fuzianna, et al.
Published: (2016)
by: Ibrahim, Fuzianna, et al.
Published: (2016)
Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat
by: Sengupta, Pinaki, et al.
Published: (2016)
by: Sengupta, Pinaki, et al.
Published: (2016)
A comparison and analysis between current literature on the subjects of supplier selection and supply chain management with the actual working practice used at Nissan Technical Centre Europe.
by: Bourke, Kieran
Published: (2012)
by: Bourke, Kieran
Published: (2012)
A bioanalytical method for quantification of telmisartan in rat plasma; development, validation and application to pharmacokinetic study
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2021)
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2021)
Mortality rate and survivability of cats diagnosed with chronic kidney disease and the effectiveness of telmisartan in management of proteinuria
by: Manoraj, Hemadevy
Published: (2018)
by: Manoraj, Hemadevy
Published: (2018)
Development and validation of a LC- MS/MS Method for simultaneous quantitation of telmisartan and pioglitazone in rat plasma
by: Das, Arindam, et al.
Published: (2016)
by: Das, Arindam, et al.
Published: (2016)
Lyophilized amorphous dispersion of telmisartan in a combined carrier−alkalizer system: formulation development and in vivo study
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2020)
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2020)
Lyophilized amorphous dispersion of telmisartan in a combined carrier–alkalizer system: formulation development and in vivo study
by: Al-Japairai, Khater A. S., et al.
Published: (2020)
by: Al-Japairai, Khater A. S., et al.
Published: (2020)
Market update: Sixty years of change in Papua New Guineaʼs fresh food marketplaces
by: Sharp, Timothy, et al.
Published: (2022)
by: Sharp, Timothy, et al.
Published: (2022)
Criterion Validity of the Child's Challenging Behavior Scale, Version 2 (CCBS-2).
by: Bourke-Taylor, H., et al.
Published: (2017)
by: Bourke-Taylor, H., et al.
Published: (2017)
Child's challenging behaviour scale, version 2 (CCBS-2): Psychometric evaluation with young children
by: Bourke-Taylor, H., et al.
Published: (2017)
by: Bourke-Taylor, H., et al.
Published: (2017)
Family functioning in families with a child with Down syndrome: A mixed methods approach
by: Povee, Kate, et al.
Published: (2012)
by: Povee, Kate, et al.
Published: (2012)
Risk of Mortality into Adulthood According to Gestational Age at Birth
by: Srinivasjois, R., et al.
Published: (2017)
by: Srinivasjois, R., et al.
Published: (2017)
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis
by: Bath, Philip M.W., et al.
Published: (2009)
by: Bath, Philip M.W., et al.
Published: (2009)
Transition to adulthood for young people with Down syndrome: Longitudinal research from the Telethon Kids Institute
by: Foley, K., et al.
Published: (2016)
by: Foley, K., et al.
Published: (2016)
Health Conditions and Their Impact among Adolescents and Young Adults with Down Syndrome
by: Pikora, T., et al.
Published: (2014)
by: Pikora, T., et al.
Published: (2014)
Special Issue: Innovations in occupational therapy measurement
by: Bourke-Taylor, H., et al.
Published: (2018)
by: Bourke-Taylor, H., et al.
Published: (2018)
Leisure participation for school-aged children with Down syndrome
by: Oates, A., et al.
Published: (2011)
by: Oates, A., et al.
Published: (2011)
Improved Survival in Down Syndrome over the Last 60 Years and the Impact of Perinatal Factors in Recent Decades
by: Glasson, E., et al.
Published: (2016)
by: Glasson, E., et al.
Published: (2016)
“Everybody else is doing it”—norm perceptions among parents of adolescents
by: Gilligan, C., et al.
Published: (2014)
by: Gilligan, C., et al.
Published: (2014)
"I have a good life": the meaning of well-being from the perspective of young adults with Down syndrome
by: Scott, Melissa, et al.
Published: (2014)
by: Scott, Melissa, et al.
Published: (2014)
Young adults with intellectual disability transitioning from school to post-school: A literature review framed within the ICF
by: Foley, K., et al.
Published: (2012)
by: Foley, K., et al.
Published: (2012)
Development and validation of a high throughput LC–MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study
by: Sengupta, Pinaki, et al.
Published: (2017)
by: Sengupta, Pinaki, et al.
Published: (2017)
Evaluating the psychometric quality of school connectedness measures: A systematic review
by: Hodges, A., et al.
Published: (2018)
by: Hodges, A., et al.
Published: (2018)
Looking forward: Occupational therapy in Australia's future
by: Brown, T., et al.
Published: (2017)
by: Brown, T., et al.
Published: (2017)
An introduction to occupational therapy in an Australian context
by: Bourke-Taylor, H., et al.
Published: (2017)
by: Bourke-Taylor, H., et al.
Published: (2017)
Occupational Therapy in Australia: Professional and Practice Issues
by: Brown, T., et al.
Published: (2017)
by: Brown, T., et al.
Published: (2017)
Satisfiers and dissatisfiers of expatriates in Malaysia / Remy Jaeggi.
by: Jaeggi, Remy
Published: (2003)
by: Jaeggi, Remy
Published: (2003)
Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men
by: Siru, R., et al.
Published: (2018)
by: Siru, R., et al.
Published: (2018)
Similar Items
-
Erratum to: 'TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial'
by: Morris, D.R., et al.
Published: (2016) -
Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): Study protocol for a randomised controlled trial
by: Rowbotham, S., et al.
Published: (2017) -
Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: Outcomes from the FAME-2 trial
by: Pinchbeck, J., et al.
Published: (2018) -
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): Study protocol for a randomised controlled trial
by: Rowbotham, S., et al.
Published: (2017) -
Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: A randomized controlled trial
by: Ahimastos, A., et al.
Published: (2013)